CompletedNCT02473185
Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance During the QbTest
Medication studyAges 18–60SwedenADHD
Understand this study
Who was this study for?
This study was for people with ADHD. Listed age limits: 18 years to 60 years. Other eligibility criteria applied.
- Listed locations
- Västerås, SwedenSee all locations and recruitment
- Activities
- Medication and placebo comparator listed across study groups
- Compensation
- Payment and expense reimbursement have not been verified.
Study information
Study start dateSeptember 2015
- Recruitment status
- Completed
- Enrollment listed in the registry
- 40
- Sponsor
- Region Västmanland
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Sweden
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT02473185
- Official title
Show the full official title
Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance During the Quantified Behavior Test in Patients With Untreated ADHD
Recruitment & locations
CompletedVästerås
Questions about this study
Who is behind this study?
The study sponsor is Region Västmanland.
Did this study involve medication?
Yes. The study involved medication, including Methylphenidate.
Who was this study for?
This study was for people with ADHD. Listed age limits: 18 years to 60 years. Other eligibility criteria applied.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meRelated studies
A 40-week, randomized, double-blind, placebo-controlled, multicenter efficacy and safety study of Ritalin® LA in the treatment of adult patients with childhood-onset ADHD
A 6-month, open-label extension to a 40-week, randomized, double-blind, placebo-controlled, multicenter efficacy and safety study of Ritalin® LA in the treatment of adult patients with childhood-on...